The Neurobiology of Addiction: Where We Have Been and Where We Are Going.

Journal of Drug Issues
George F Koob, Eric J Simon

Abstract

A number of dramatic breakthroughs in the neurobiology of addiction have occurred in the past 40 years. Two domains will be highlighted: the neurocircuitry of addiction and the molecular biology of addiction targets. The neurobiological substrates for the reinforcing effects of drugs of abuse have been largely identified both at the initial site of action and in the circuitry involved. In human imaging studies, decreases in dopaminergic function have been identified as a key element of addiction, lending support for research on the role of dopamine in addiction. Three novel areas currently are emerging: the role of deficits in frontal cortex functioning, changes in the brain neurocircuitry that convey long-term vulnerability to relapse, and the role of nondopaminergic systems in the neuroadaptations associated with the development of drug dependence. Parallel to these functional changes have been major advances in our understanding of the molecular biology of addiction; the greatest contribution has been in the understanding of the molecular mechanisms of opioid action. This paper reviews the major developments in our understanding of the molecular biology of the endogenous opioid system and the use of genomics to advance our k...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B L KiefferC G Hirth
Dec 28, 1992·Science·C J EvansR H Edwards
May 1, 1992·Trends in Pharmacological Sciences·G F Koob
Jul 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·E J SimonI Edelman
Mar 9, 1973·Science·C B Pert, S H Snyder
Jan 1, 1980·Pharmacology, Biochemistry, and Behavior·R A Wise
Feb 1, 1994·Trends in Neurosciences·M HeiligK T Britton
Oct 13, 1998·Neuron·G F KoobF E Bloom
Dec 20, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G F Koob, M Le Moal
May 17, 2002·Progress in Neurobiology·Brigitte L Kieffer, Claire Gavériaux-Ruff
Oct 29, 2002·Psychopharmacology·Yavin ShahamJane Stewart
Nov 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George F Koob
Aug 7, 2004·The Journal of Pharmacology and Experimental Therapeutics·Stephen C Heinrichs, George F Koob
Nov 20, 2004·Nature Reviews. Neuroscience·Nora D Volkow, Ting-Kai Li
Oct 28, 2005·Nature Neuroscience·George F Koob, Michel Le Moal
Jul 20, 2007·The New England Journal of Medicine·Charles A Schiffer
Dec 25, 2007·Annual Review of Psychology·George F Koob, Michel Le Moal
Jul 11, 2008·Neuron·George F Koob

❮ Previous
Next ❯

Citations

Feb 14, 2007·Experimental and Clinical Psychopharmacology·Stacey C Sigmon
Jun 24, 2014·Addictive Behaviors·Paulo LopesAna R Delgado
Sep 28, 2012·Expert Opinion on Drug Delivery·Michael Soyka
Jul 4, 2012·Neuroscience·P KoesterJ Daumann
Oct 5, 2011·The Journal of Pain : Official Journal of the American Pain Society·Sheetal KircherMichelle Lofwall
Jan 27, 2015·Acta Paediatrica·Radhika RuwanpathiranaJu Lee Oei
May 18, 2013·Physiology & Behavior·Caroline DavisJames L Kennedy
Feb 25, 2015·Physiology & Behavior·Ian C WebbLique M Coolen
Jul 2, 2016·Neuroscience·M Paola CastelliGian Luigi Gessa
Nov 20, 2016·The European Journal of Neuroscience·Felix BetzlerNina Romanczuk-Seiferth
Feb 9, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip KoesterJoerg Daumann
Dec 12, 2019·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Darin R BrownKatie Witkiewitz
Sep 26, 2013·Journal of Experimental Botany·Ingo Burgert, Tobias Keplinger
Aug 22, 2020·Psychopharmacology·Daniel LustbergDavid Weinshenker
Nov 21, 2015·The American Journal on Addictions·Daryl ShorterThomas R Kosten
Nov 18, 2016·The Journal of Toxicological Sciences·Nozomi AsaokaShuji Kaneko
Nov 2, 2017·Frontiers in Psychology·Alissa MoreBonnie J Furzer
Apr 30, 2019·Frontiers in Behavioral Neuroscience·Deena M WalkerEric J Nestler
Jan 29, 2020·Cold Spring Harbor Perspectives in Medicine·Marisa RobertoSophia Khom
Mar 18, 2020·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Patrycja KupnickaIrena Baranowska-Bosiacka
Feb 23, 2017·Neuroscience and Biobehavioral Reviews·Marc Fakhoury
May 21, 2021·Scientific Reports·Yusuf S AlthobaitiZahoor A Shah
Aug 9, 2021·Addictive Behaviors·Aleksandra GaworThomas Wilcockson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Trends in Neurosciences
Geoffrey SchoenbaumThomas A Stalnaker
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Yuliya S NikolovaA R Hariri
© 2021 Meta ULC. All rights reserved